The panel backed the vaccine, known as mFLUSIVA, for adults aged 50 years and older, concluding that its benefits outweigh ...
A Food and Drug Administration advisory panel on Thursday recommended the approval of Moderna’s mRNA-based flu shot for older ...
Breaking news and analysis from time.com. Politics, world news, photos, video, tech reviews, health, science, and ...
U.S. Food and ‌Drug Administration staff reviewers said on Tuesday data demonstrating an immune response to Moderna's flu ...